Glen Babcock – Trademark Portfolio

Entity Type: 01

Glen Babcock holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include OPPORTUNITY, THE ORIGINAL CO2 BAG, and CO2 THE ORIGINAL CO2 BAG. The owner is based in Missoula, MT.

PO Box 1591

Missoula, MT 598061591

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Glen Babcock's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (6 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Glen Babcock have?

Glen Babcock has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 abandoned, 1 cancelled.

What trademark classes does Glen Babcock file in?

Glen Babcock files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Glen Babcock's most well-known trademarks?

Glen Babcock's registered trademark portfolio includes well-known marks such as OPPORTUNITY, THE ORIGINAL CO2 BAG, and CO2 THE ORIGINAL CO2 BAG. These are among 3 currently registered trademarks in the portfolio.

What is Glen Babcock's trademark registration success rate?

Glen Babcock has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.